Alexandra J van den Broek
Overview
Explore the profile of Alexandra J van den Broek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, van den Broek A, Schmidt M
Breast Cancer Res Treat
. 2021 Jun;
188(3):821-823.
PMID: 34132937
No abstract available.
2.
Lakeman I, van den Broek A, Vos J, Barnes D, Adlard J, Andrulis I, et al.
Genet Med
. 2021 Jun;
23(9):1726-1737.
PMID: 34113011
Purpose: To evaluate the association between a previously published 313 variant-based breast cancer (BC) polygenic risk score (PRS) and contralateral breast cancer (CBC) risk, in BRCA1 and BRCA2 pathogenic variant...
3.
Giardiello D, Hauptmann M, Steyerberg E, Adank M, Akdeniz D, Blom J, et al.
Breast Cancer Res Treat
. 2020 Apr;
181(2):423-434.
PMID: 32279280
Background: Three tools are currently available to predict the risk of contralateral breast cancer (CBC). We aimed to compare the performance of the Manchester formula, CBCrisk, and PredictCBC in patients...
4.
Giardiello D, Steyerberg E, Hauptmann M, Adank M, Akdeniz D, Blomqvist C, et al.
Breast Cancer Res
. 2019 Dec;
21(1):144.
PMID: 31847907
Background: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the consequent burden of further treatment and potentially less favorable prognosis. We aimed to develop and validate...
5.
Akdeniz D, Schmidt M, Seynaeve C, McCool D, Giardiello D, van den Broek A, et al.
Breast
. 2018 Dec;
44:1-14.
PMID: 30580169
Background: The risk of developing metachronous contralateral breast cancer (CBC) is a recurrent topic at the outpatient clinic. We aimed to provide CBC risk estimates of published patient, pathological, and...
6.
van den Broek A, Schmidt M, J van t Veer L, Oldenburg H, Rutgers E, Russell N, et al.
Ann Surg
. 2018 May;
270(2):364-372.
PMID: 29727326
Objective: To investigate the effects of different types of surgery on breast cancer prognosis in germline BRCA1/BRCA2 mutation carriers compared with noncarriers. Summary Of Background Data: Although breast-conserving therapy (breast-conserving...
7.
Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla M, Wang Q, et al.
Breast Cancer Res
. 2017 Nov;
19(1):119.
PMID: 29116004
Background: Previous studies have shown that reproductive factors are differentially associated with breast cancer (BC) risk by subtypes. The aim of this study was to investigate associations between reproductive factors...
8.
Candido Dos Reis F, Wishart G, Dicks E, Greenberg D, Rashbass J, Schmidt M, et al.
Breast Cancer Res
. 2017 May;
19(1):58.
PMID: 28532503
Background: PREDICT is a breast cancer prognostic and treatment benefit model implemented online. The overall fit of the model has been good in multiple independent case series, but PREDICT has...
9.
Engelhardt E, van den Broek A, Linn S, Wishart G, Rutgers E, van de Velde A, et al.
Eur J Cancer
. 2017 Apr;
78:37-44.
PMID: 28412587
Importance: Online prognostication tools such as PREDICT and Adjuvant! are increasingly used in clinical practice by oncologists to inform patients and guide treatment decisions about adjuvant systemic therapy. However, their...
10.
Schmidt M, van den Broek A, Tollenaar R, Smit V, Westenend P, Brinkhuis M, et al.
J Natl Cancer Inst
. 2017 Apr;
109(8).
PMID: 28376189
Background: The primary aim of the study was to investigate prognosis and long-term survival in young breast cancer patients with a BRCA1 or BRCA2 germline mutation compared with noncarriers. The...